US5521061A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Enhancement of probe signal in nucleic acid-mediated in-situ hybridization studies
Assignee: Abbott Molecular Inc
•
Filing: 1992-07-17
•
Granted: 1996-05-28
•
Expires: 2012-07-17
Abstract
Abstract Solutions useful for hybridizing cells and viruses with nucleic acid and antibody probes, their usefulness increased due to the presence of permeation enhancers and signal enhancers, including permeation enhancers; also the hybridization processes wherein the solutions are used.
Inventors
- 👤 Joel Bresser
- 👤 Michael L. Cubbage
- 👤 Nagindra Prashad
- 👤 William D. Weber
- 👤 Shyh Chen Ju
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 21:16
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6876; C12Q1/6813; C12Q1/6832; C12Q1/6841; Y; Y10; Y10S; Y10S435/00; Y10S435/81
Claims Analysis
Total Claims: 66
Claim 1
Independent Claim
346 words
A process of detecting a target molecule in a biological entity which process comprises the steps of: (1) contacting the biological entity with an assay solution comprising a probe molecule so as to allow the probe molecule to bind to the target molecule, and (2) detecting the probe molecule that is in the biological entity after said probe molecule has bound to the target molecule said bound probe detection being indicative of the presence of the target molecule in the biological entity, wherein the assay solution comprises a probe molecule and DMSO (2 to 20 percent) and one or more compounds selected from the group, an alcohol (2 to 20 percent), an aliphatic alkane (2 to 20 percent), an alkene (2 to 20 percent), a fatty acid ester (2 to 20 percent) of the formula R 1 (COO)R 2 , an amide or lactam (2 to 15 percent) of the formula R 3 (NH)(CO)R 4 , and an organic silane (2 to 20 percent) of the formula (SiR 5 R 6 R 7 )N(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )--(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )O(SiR 8 R 9 R 10 ), or (SiR 5 R 6 O)(SiR.sub. 7 R 8 )(SiR 9 R 10 O), the combined volumes of DMSO and the compounds selected from the group not being more than 30 percent of the assay solution (v/v), wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are alkyl moieties, R 1 and R 2 may be covalently joined to form a ring structure, and R 3 and R 4 may be covalently joined to form a ring structure, and a percent designated in parenthesis after a compound refers to the compound's concentration expressed as percent of the assay solution (v/v), said probe molecule being a nucleic acid probe, said biological entity being either a cell or a virus.
Claim 2
Dependent Claim
346 words
A process of detecting a target molecule in a biological entity which process comprises the steps of: (1) contacting the biological entity with an assay solution comprising a probe molecule so as to allow the probe molecule to bind to the target molecule, and (2) detecting the probe molecule that is in the biological entity after said probe molecule has bound to the target molecule said bound probe detection being indicative of the presence of the target molecule in the biological entity, wherein the assay solution comprises a probe molecule and DMSO (2 to 20 percent) and one or more compounds selected from the group, an alcohol (2 to 20 percent), an aliphatic alkane (2 to 20 percent), an alkene (2 to 20 percent), a fatty acid ester (2 to 20 percent) of the formula R 1 (COO)R 2 , an amide or lactam (2 to 15 percent) of the formula R 3 (NH)(CO)R 4 , and an organic silane (2 to 20 percent) of the formula (SiR 5 R 6 R 7 )N(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )--(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )O(SiR 8 R 9 R 10 ), or (SiR 5 R 6 O)(SiR.sub. 7 R 8 )(SiR 9 R 10 O), the combined volumes of DMSO and the compounds selected from the group not being more than 30 percent of the assay solution (v/v), wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are alkyl moieties, R 1 and R 2 may be covalently joined to form a ring structure, and R 3 and R 4 may be covalently joined to form a ring structure, and a percent designated in parenthesis after a compound refers to the compound's concentration expressed as percent of the assay solution (v/v), said probe molecule being a nucleic acid probe, said biological entity being either a cell or a virus.
Claim 3
Dependent Claim
178 words
A process of claim 1 wherein the alcohol has between 2 and 40 carbon atoms; that aliphatic alkane has between 10 and 60 carbon atoms; the alkene has between 10 and 60 carbon atoms; that R 1 plus R 2 together have between 3 and 20 carbon atoms and, where R 1 and R 2 are not covalently joined so as to form a ring, R 1 and R 2 each have at least 1 carbon atoms; that R 3 plus R 4 together have between 2 and 20 carbon atoms and, where R 3 and R 4 are not covalently joined so as to form a ring, R 3 and R 4 each have at least 1 carbon atom; and that R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , each have at least one carbon atom, that the six alkyl carbon structures,R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , together have no more than 20 carbon atoms.
Claim 4
Dependent Claim
175 words
A process of claim 2 wherein the alcohol has between 3 and 30 atoms, aliphatic alkane has between 20 and 40 carbon atoms, the alkene has between 20 and 40 carbon atoms, R 1 plus R 2 together have between 3 and 10 carbon atoms and, where R 1 and R 2 are not covalently joined so as to form a ring, R 1 and R 2 each have at least 3 carbon atoms; R 3 plus R 4 together have between 2 and 10 carbon atoms and, where R 3 and R 4 are not covalently joined so as to form a ring, R 3 and R 4 each have at least 1 carbon atoms; and and that R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , each have at least one carbon atom, that the six alkyl carbon structures,R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , together have no more than 10 carbon atoms.
Claim 5
Dependent Claim
24 words
A process of claim 1 wherein during step (1) the biological entity is suspended in solution and is not immobilized on a solid support.
Claim 6
Dependent Claim
18 words
A process of claim 1 wherein during step (1) the biological entity is immobilized on a solid support.
Claim 7
Dependent Claim
12 words
A process of claim 1 wherein the biological entity is a cell.
Claim 8
Dependent Claim
12 words
A process of claim 6 wherein the cell is a eukaryotic cell.
Claim 9
Dependent Claim
12 words
A process of claim 7 wherein the cell is a human cell.
Claim 10
Dependent Claim
14 words
A process of claim 8 wherein the probe is specific for viral nucleic acid.
Claim 11
Dependent Claim
12 words
A process of claim 6 wherein the cell is a prokaryotic cell.
Claim 12
Dependent Claim
12 words
A process of claim 1 where the biological entity is a virus.
Claim 13
Dependent Claim
14 words
A process of claim 6 wherein the probe molecule is a nucleic acid molecule.
Claim 14
Dependent Claim
21 words
A process of claim 2 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 15
Dependent Claim
21 words
A process of claim 3 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 16
Dependent Claim
14 words
A process of claim 1 wherein the probe molecule is a nucleic acid molecule.
Claim 17
Dependent Claim
16 words
A process of claim 9 wherein the viral nucleic acid is human immunodeficiency virus nucleic acid.
Claim 18
Dependent Claim
141 words
A process of detecting a target molecule in a biological entity which process comprises the steps of: (1) contacting the biological entity with an assay solution comprising a probe molecule so as to allow the probe molecule to bind to the target molecule, and (2) detecting the probe molecule after it has bound to the target molecule said bound probe detection being indicative of the presence of the target molecule in the biological entity, said assay solution comprising the probe molecule, DMSO, either an aliphatic alkane or an alkene, and at least one other compound selected from the group, an alcohol, a cyclodextrin, a fatty acid ester, an amide or lactam, and an organic silane, said probe molecule being either a probe comprising a nucleic acid or a probe comprising an antibody, said biological entity being a cell or a virus.
Claim 19
Dependent Claim
141 words
A process of detecting a target molecule in a biological entity which process comprises the steps of: (1) contacting the biological entity with an assay solution comprising a probe molecule so as to allow the probe molecule to bind to the target molecule, and (2) detecting the probe molecule after it has bound to the target molecule said bound probe detection being indicative of the presence of the target molecule in the biological entity, said assay solution comprising the probe molecule, DMSO, either an aliphatic alkane or an alkene, and at least one other compound selected from the group, an alcohol, a cyclodextrin, a fatty acid ester, an amide or lactam, and an organic silane, said probe molecule being either a probe comprising a nucleic acid or a probe comprising an antibody, said biological entity being a cell or a virus.
Claim 20
Dependent Claim
20 words
A process of claim 17 wherein the assay solution contains about 10 percent of an alcohol derivative of polyoxyethylene ether.
Claim 21
Dependent Claim
19 words
The process of claim 17 wherein an alkane and at least one other compound are selected from the group.
Claim 22
Dependent Claim
29 words
A process of claim 19 wherein the combined volumes of DMSO and the compounds selected from the group are not more than 20 percent of the assay solution (v/v).
Claim 23
Dependent Claim
14 words
A process of claim 20 wherein the concentration of DMSO is about 10 percent.
Claim 24
Dependent Claim
15 words
A process of claim 21 wherein the concentration of the alkane is about 5 percent.
Claim 25
Dependent Claim
21 words
A process of claim 17 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 26
Dependent Claim
21 words
A process of claim 18 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 27
Dependent Claim
21 words
A process of claim 19 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 28
Dependent Claim
21 words
A process of claim 20 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 29
Dependent Claim
21 words
A process of claim 21 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 30
Dependent Claim
21 words
A process of claim 22 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 31
Dependent Claim
16 words
A process of claim 20 wherein the probe is specific for human immunodeficiency virus nucleic acid.
Claim 32
Dependent Claim
260 words
A process of detecting a target molecule in a biological entity which process comprises the steps of: (1) contacting the biological entity with an assay solution comprising a probe molecule so as to allow the probe molecule to bind to the target molecule, (2) removing the biological entity from the assay solution, (3) creating a suspension of the biological entity in a detection solution, said detection solution comprising a signal enhancing compound, and (4) while the biological entity is in the suspension created in step (3), detecting a signal that is light quanta generated directly or indirectly by the target-bound probe molecule said bound probe detection being indicative of the presence of the target molecule in the biological entity, wherein the detection solution comprises one or more compounds selected from the group, an alcohol (2 to 20 percent), an aliphatic alkane (2 to 20 percent), an alkene (2 to 20 percent), a fatty acid ester (2 to 20 percent) of the formula R 1 (COO)R 2 , an amide or lactam (2 to 15 percent) of the formula R 3 (NH)(CO)R 4 , and an organic silane (2 to 20 percent) of the formula R 5 SiOSiR 6 , wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 , are alkyl carbon structures, the combined volumes of DMSO, if DMSO is present, and the compounds selected from the group not being more than 30 percent of the detection solution (v/v), wherein said biological entity is either a cell or virus.
Claim 33
Dependent Claim
260 words
A process of detecting a target molecule in a biological entity which process comprises the steps of: (1) contacting the biological entity with an assay solution comprising a probe molecule so as to allow the probe molecule to bind to the target molecule, (2) removing the biological entity from the assay solution, (3) creating a suspension of the biological entity in a detection solution, said detection solution comprising a signal enhancing compound, and (4) while the biological entity is in the suspension created in step (3), detecting a signal that is light quanta generated directly or indirectly by the target-bound probe molecule said bound probe detection being indicative of the presence of the target molecule in the biological entity, wherein the detection solution comprises one or more compounds selected from the group, an alcohol (2 to 20 percent), an aliphatic alkane (2 to 20 percent), an alkene (2 to 20 percent), a fatty acid ester (2 to 20 percent) of the formula R 1 (COO)R 2 , an amide or lactam (2 to 15 percent) of the formula R 3 (NH)(CO)R 4 , and an organic silane (2 to 20 percent) of the formula R 5 SiOSiR 6 , wherein R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 , are alkyl carbon structures, the combined volumes of DMSO, if DMSO is present, and the compounds selected from the group not being more than 30 percent of the detection solution (v/v), wherein said biological entity is either a cell or virus.
Claim 34
Dependent Claim
17 words
A process of claim 30 wherein the light quanta is generated directly by the target-bound probe molecule.
Claim 35
Dependent Claim
26 words
A process of claim 30 wherein the probe molecule comprises a fluorescent moiety and the light quanta detected in step (4) is emitted by that moiety.
Claim 36
Dependent Claim
153 words
A process of claim 30 wherein the alcohol has between 2 and 40 carbon atoms; that aliphatic alkane has between 10 and 60 carbon atoms; that the alkene has between 10 and 60 carbon atoms, that R 1 plus R 2 together have between 3 and 20 carbon atoms and, where R 1 and R 2 are not covalently joined so as to form a ring, R 1 and R 2 each have at least one carbon atom; that R 3 plus R 4 together have between 2 and 20 carbon atoms and, where R 3 and R 4 are not covalently joined so as to form a ting, R 3 and R 4 each have at least one carbon atom; and that R 5 and R 6 each have at least one carbon atom, that the alkyl carbon structures, R 5 and R 6 together have no more than 20 carbon atoms.
Claim 37
Dependent Claim
140 words
A process of claim 33 wherein the alcohol has between 3 and 30 carbon atoms; that aliphatic alkane has between 20 and 40 carbon atoms; R 1 plus R 2 together have between 3 and 10 carbon atoms and, where R 1 and R 2 are not covalently joined so as to form a ring, R 1 and R 2 each have at least one carbon atom; R 3 plus R 4 together have between 3 and 10 carbon atoms and, where R 3 and R 4 are not covalently joined so as to form a ring, R 3 and R 4 each have at least one carbon atom; and R 5 and R 6 each have at least one carbon atom, that the alkyl carbon structures, R 5 and R 6 together have no more than 20 carbon atoms.
Claim 38
Dependent Claim
21 words
A process of claim 30 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 39
Dependent Claim
21 words
A process of claim 31 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 40
Dependent Claim
21 words
A process of claim 32 wherein the probe molecule is a nucleic acid molecule and the biological entity is a cell.
Claim 41
Dependent Claim
151 words
A process of claim 30 wherein the alcohol has between 2 and 40 carbon atoms, the aliphatic alkane has between 10 and 60 carbon atoms; the alkene has between 10 and 60 carbon atoms, that R 1 plus R 2 together have between 3 and 20 carbon atoms and, where R 1 and R 2 are not covalently joined so as to form a ring, R 1 and R 2 each have at least one carbon atom; that R 3 plus R 4 together have between 2 and 20 carbon atoms and, where R 3 and R 4 are not covalently joined so as to form a ring, R 3 and R 4 each have at least one carbon atom; and that R 5 and R 6 each have at least one carbon atom, that the alkyl carbon structures,R 5 and R 6 together have no more than 20 carbon atoms.
Claim 42
Dependent Claim
140 words
A process of claim 38 wherein the alcohol has between 3 and 30 carbon atoms, the aliphatic alkane has between 20 and 40 carbon atoms, R 1 plus R 2 together have between 3 and 10 carbon atoms and, where R 1 and R 2 are not covalently joined so as to form a ring, R 1 and R 2 each have at least 3 carbon atoms; R 3 plus R 4 together have between 3 and 10 carbon atoms and, where R 3 and R 4 are not covalently joined so as to form a ring, R 3 and R 4 each have at least 1 carbon atom; and R 5 and R 6 , each have at least one carbon atom, that the alkyl carbon structures,R 5 and R 6 together have no more than 10 carbon atoms.
Claim 43
Dependent Claim
101 words
A process of detecting a target molecule in a biological entity which process comprises the steps of: (1) contacting the biological entity with an assay solution comprising a probe molecule so as to allow the probe molecule to bind to the target molecule, and (2) detecting the probe molecule that is in the biological entity after said probe molecule has bound to the target molecule said bound probe detection being indicative of the presence of the target molecule in the biological entity, wherein the assay solution comprises a cyclodextrin, and wherein said biological entity is either a cell or a virus.
Claim 44
Dependent Claim
101 words
A process of detecting a target molecule in a biological entity which process comprises the steps of: (1) contacting the biological entity with an assay solution comprising a probe molecule so as to allow the probe molecule to bind to the target molecule, and (2) detecting the probe molecule that is in the biological entity after said probe molecule has bound to the target molecule said bound probe detection being indicative of the presence of the target molecule in the biological entity, wherein the assay solution comprises a cyclodextrin, and wherein said biological entity is either a cell or a virus.
Claim 45
Dependent Claim
23 words
A process of claim 40 wherein during step (1) the biological entity is suspended in solution and not immobilized on a solid support.
Claim 46
Dependent Claim
18 words
A process of claim 40 wherein during step (1) the biological entity is immobilized on a solid support.
Claim 47
Dependent Claim
12 words
A process of claim 40 wherein the biological entity is a cell.
Claim 48
Dependent Claim
12 words
A process of claim 43 wherein the cell is a eukaryotic cell.
Claim 49
Dependent Claim
12 words
A process of claim 44 wherein the cell is a human cell.
Claim 50
Dependent Claim
14 words
A process of claim 45 wherein the probe is specific for viral nucleic acid.
Claim 51
Dependent Claim
152 words
A process of detecting a target molecule in a biological entity which process comprises the steps of: (1) contacting the biological entity with an assay solution comprising a probe molecule so as to allow the probe molecule to bind to the target molecule, (2) removing the biological entity from the assay solution, (3) creating a suspension of the biological entity in a detection solution, said detection solution comprising a signal enhancing compound, and (4) while the biological entity is in the suspension created in step (3), detecting a signal that is light quanta generated directly or indirectly by the target-bound probe molecule said bound probe detection being indicative of the presence of the target molecule in the biological entity, said signal enhancing compound selected from the group consisting of an aliphatic alkane, a cyclodextrin, an amide or lactam, and an organic silane, wherein said biological entity is either a cell or virus.
Claim 52
Dependent Claim
152 words
A process of detecting a target molecule in a biological entity which process comprises the steps of: (1) contacting the biological entity with an assay solution comprising a probe molecule so as to allow the probe molecule to bind to the target molecule, (2) removing the biological entity from the assay solution, (3) creating a suspension of the biological entity in a detection solution, said detection solution comprising a signal enhancing compound, and (4) while the biological entity is in the suspension created in step (3), detecting a signal that is light quanta generated directly or indirectly by the target-bound probe molecule said bound probe detection being indicative of the presence of the target molecule in the biological entity, said signal enhancing compound selected from the group consisting of an aliphatic alkane, a cyclodextrin, an amide or lactam, and an organic silane, wherein said biological entity is either a cell or virus.
Claim 53
Dependent Claim
13 words
A process of claim 47 wherein the signal enhancing compound is a cyclodextrin.
Claim 54
Dependent Claim
14 words
A process of claim 47 wherein the signal enhancing compound is an aliphatic alkane.
Claim 55
Dependent Claim
15 words
A process of claim 47 wherein the signal enhancing compound is an amide or lactam.
Claim 56
Dependent Claim
14 words
A process of claim 47 wherein the signal enhancing compound is an organic silane.
Claim 57
Dependent Claim
98 words
A kit that comprises a probe molecule and an assay solution that comprises DMSO and squalane and one or more compounds selected from the group, an alcohol, a fatty acid ester, an amide or lactam, and an organic silane, the combined volumes of DMSO and squalane and the compound or compounds selected from the group not being more than about 20 percent of the solution (v/v), the volume of DMSO being between about 2 percent and 16 percent of the solution (v/v), the amount of squalane being between about 2 percent and 16 percent of the solution (v/v).
Claim 58
Dependent Claim
98 words
A kit that comprises a probe molecule and an assay solution that comprises DMSO and squalane and one or more compounds selected from the group, an alcohol, a fatty acid ester, an amide or lactam, and an organic silane, the combined volumes of DMSO and squalane and the compound or compounds selected from the group not being more than about 20 percent of the solution (v/v), the volume of DMSO being between about 2 percent and 16 percent of the solution (v/v), the amount of squalane being between about 2 percent and 16 percent of the solution (v/v).
Claim 59
Dependent Claim
255 words
A kit that comprises a probe molecule and a solution that comprises DMSO (2 to 20 percent) and one or more compounds selected from the group, an alcohol (2 to 20 percent), an aliphatic alkane (2 to 20 percent), an alkene (2 to 20 percent), a fatty acid ester (2 to 20 percent) of the formula R 1 (COO)R 2 , an amide or lactam (2 to 15 percent) of the formula R 3 (NH)(CO)R 4 , and an organic silane (2 to 20 percent) of the formula (SiR 5 R 6 R 7 )N(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )--(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )O(SiR 8 R 9 R 10 ), or (SiR 5 R 6 O)(SiR 7 R 8 O)(SiR 9 R 10 O), the combined volumes of DMSO and the compounds selected from the group not being more than 30 percent of the solution (v/v), wherein R 1 , R 2 , R 3 , R 4 , R 5 , P 6 , R 7 , R 8 , P 9 , and R 10 are alkyl moieties, R 1 and R 2 may be covalently joined to form a ring structure, and R 3 and R 4 may be covalently joined to form a ring structure, and a percent designated in parenthesis after a compound refers to the compound's concentration expressed as percent of the solution (v/v), said probe molecule being a nucleic acid probe.
Claim 60
Dependent Claim
255 words
A kit that comprises a probe molecule and a solution that comprises DMSO (2 to 20 percent) and one or more compounds selected from the group, an alcohol (2 to 20 percent), an aliphatic alkane (2 to 20 percent), an alkene (2 to 20 percent), a fatty acid ester (2 to 20 percent) of the formula R 1 (COO)R 2 , an amide or lactam (2 to 15 percent) of the formula R 3 (NH)(CO)R 4 , and an organic silane (2 to 20 percent) of the formula (SiR 5 R 6 R 7 )N(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )--(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )O(SiR 8 R 9 R 10 ), or (SiR 5 R 6 O)(SiR 7 R 8 O)(SiR 9 R 10 O), the combined volumes of DMSO and the compounds selected from the group not being more than 30 percent of the solution (v/v), wherein R 1 , R 2 , R 3 , R 4 , R 5 , P 6 , R 7 , R 8 , P 9 , and R 10 are alkyl moieties, R 1 and R 2 may be covalently joined to form a ring structure, and R 3 and R 4 may be covalently joined to form a ring structure, and a percent designated in parenthesis after a compound refers to the compound's concentration expressed as percent of the solution (v/v), said probe molecule being a nucleic acid probe.
Claim 61
Dependent Claim
252 words
A solution comprising a probe molecule and DMSO (2 to 20 percent) and one or more compounds selected from the group, an alcohol (2 to 20 percent), an aliphatic alkane (2 to 20 percent), an alkene (2 to 20 percent), a fatty acid ester (2 to 20 percent) of the formula R 1 (COO)R 2 , an amide or lactam (2 to 15 percent) of the formula R 3 (NH)(CO)R 4 , and an organic silane (2 to 20 percent) of the formula (SiR 5 R 6 R 7 )N(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )--(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )O(SiR 8 R 9 R 10 ), or (SiR 5 R 6 O)(SiR 7 R 8 O)(SiR 9 R 1 O), the combined volumes of DMSO and the compounds selected from the group not being more than 30 percent of the assay solution (v/v), wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are alkyl moieties, R 1 and R 2 may be covalently joined to form a ring structure, and R 3 and R 4 may be covalently joined to form a ring structure, and a percent designated in parenthesis after a compound refers to the compound's concentration expressed as percent of the solution (v/v), wherein said probe molecule is a nucleic acid probe.
Claim 62
Dependent Claim
252 words
A solution comprising a probe molecule and DMSO (2 to 20 percent) and one or more compounds selected from the group, an alcohol (2 to 20 percent), an aliphatic alkane (2 to 20 percent), an alkene (2 to 20 percent), a fatty acid ester (2 to 20 percent) of the formula R 1 (COO)R 2 , an amide or lactam (2 to 15 percent) of the formula R 3 (NH)(CO)R 4 , and an organic silane (2 to 20 percent) of the formula (SiR 5 R 6 R 7 )N(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )--(SiR 8 R 9 R 10 ), (SiR 5 R 6 R 7 )O(SiR 8 R 9 R 10 ), or (SiR 5 R 6 O)(SiR 7 R 8 O)(SiR 9 R 1 O), the combined volumes of DMSO and the compounds selected from the group not being more than 30 percent of the assay solution (v/v), wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , and R 10 are alkyl moieties, R 1 and R 2 may be covalently joined to form a ring structure, and R 3 and R 4 may be covalently joined to form a ring structure, and a percent designated in parenthesis after a compound refers to the compound's concentration expressed as percent of the solution (v/v), wherein said probe molecule is a nucleic acid probe.
Claim 63
Dependent Claim
100 words
A solution that comprises a probe and DMSO and squalane and one or more compounds selected from the group, an alcohol, a fatty acid ester, an amide or lactam, and an organic silane, the combined volumes of DMSO and squalane and the compound or compounds selected from the group not being more than about 20 percent of the solution (v/v), the volume of DMSO being between about 2 per cent and 16 percent of the solution (v/v), the amount of squalane being between about 2 percent and 16 percent of the solution (v/v), said probe being a nucleic acid molecule.
Claim 64
Dependent Claim
100 words
A solution that comprises a probe and DMSO and squalane and one or more compounds selected from the group, an alcohol, a fatty acid ester, an amide or lactam, and an organic silane, the combined volumes of DMSO and squalane and the compound or compounds selected from the group not being more than about 20 percent of the solution (v/v), the volume of DMSO being between about 2 per cent and 16 percent of the solution (v/v), the amount of squalane being between about 2 percent and 16 percent of the solution (v/v), said probe being a nucleic acid molecule.
Claim 65
Dependent Claim
178 words
A solution of claim 28 wherein the alcohol has between 2 and 40 carbon atoms; that aliphatic alkane has between 10 and 60 carbon atoms; the alkene has between 10 and 60 carbon atoms; that R 1 plus R 2 together have between 3 and 20 carbon atoms and, where R 1 and R 2 are not covalently joined so as to form a ring, R 1 and R 2 each have at least 1 carbon atoms; that R 3 plus R 4 together have between 2 and 20 carbon atoms and, where R 3 and R 4 are not covalently joined so as to form a ring, R 3 and R 4 each have at least 1 carbon atom; and that R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , each have at least one carbon atom, that the six alkyl carbon structures,R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , together have no more than 20 carbon atoms.
Claim 66
Dependent Claim
174 words
A solution of claim 56 wherein the alcohol has between 3 and 30 atoms, aliphatic alkane has between 20 and 40 carbon atoms, the alkene has between 20 and 40 carbon atoms, R 1 plus R 2 together have between 3 and 10 carbon atoms and, where R 1 and R 2 are not covalently joined so as to form a ring, R 1 and R 2 each have at least 3 carbon atoms; R 3 plus R 4 together have between 2 and 10 carbon atoms and, where R 3 and R 4 are not covalently joined so as to form a ring, R 3 and R 4 each have at least 1 carbon atoms; and that R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , each have at least one carbon atom, that the six alkyl carbon structures,R 5 , R 6 , R 7 , R 8 , R 9 and R 10 , together have no more than 10 carbon atoms.
References Cited (Backward Citations)
US4034073A
Cited
US4121975A
Cited
US4302204A
Cited
US4423153A
Cited
US4483920A
Cited
EP0238332A2
Cited
US5037745A
Cited
US4798804A
Cited
US4886741A
Cited
US5032503A
Cited
US5130238A
Cited
WO1990002173A1
Cited
US5077210A
Cited
WO1990010715A1
Cited
WO1991002088A1
Cited
US5106730A
Cited
US5124444A
Cited
US5376529A
Cited
US5166195A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-05-28 | 1999-11-27 | 2000-05-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-05-28 | 2003-11-27 | 2004-05-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-05-28 | 2007-11-27 | 2008-05-28 | $7700.00 | Window Closed / Lapsed |